Periodic Report - TINN2 (Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates)
Project ID: 260908Funded under: FP7-HEALTH
This is the summary report of the TINN2 project, funded under the European Commission (EC)'s Seventh Framework Programme (FP7). The aim of TINN2 is to evaluate the antibiotic azithromycin, included in the European Medicines Agency (EMA) priority list of the therapeutic areas that need specific drug evaluation in preterm and term neonates. TINN2 involves European leaders in neonatology, paediatric pharmacology, methodology and several small and medium-sized enterprises (SMEs) that will establish links with ethical bodies and regulatory authorities. The report describes the work performed so far and discusses the expected results and their use. A list of the partners is also given.
Download application/zip (13703)
Record Number: 14159 / Last updated on: 2013-01-08